Recovery First Treatment Center is a licensed substance use treatment provider in Hollywood, FL, listed in the SAMHSA treatment directory. Clients can live on site in a residential program while they complete treatment. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientResidential/24-hour residentialOutpatient day treatment or partial hospitalizationIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentShort-term residential
Type of care
Substance use treatment
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
IHS/Tribal/Urban (ITU) fundsFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than Medicaid
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState mental health departmentThe Joint Commission
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
4343 South State Road 7, Suite 101, Fort Lauderdale, FL 33314
OutpatientOutpatient day treatment or partial hospitalizationIntensive outpatient treatmentIHS/Tribal/Urban (ITU) fundsFederal military insurance (e.g., TRICARE)
OutpatientResidential/24-hour residentialOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicaid
OutpatientOutpatient detoxificationOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare